Article
Robust and rapid pipeline for the development of mRNA vaccine for the fast-emerging SARS-CoV-2 variants
2022-10-17
Abstract excerpt
Recently, genomics has gained a lot of attention in the field of bio-therapeutics, vaccines, and gene therapy. We have developed a robust pipeline for establishing the mRNA vaccine portfolio to address the current pandemic and endemic of COVID-19, infectious diseases, and cancer. We have designed and assembled approximately 4000 base pair DNA encoding the spike protein of the SARS-CoV-2 Omicron variant (B.1.1.529)...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 40a9190b-bf27-5b52-8d4d-bf6174655941
- DOI
- 10.21203/rs.3.rs-2074769/v1
